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Next generation sequencing has revolutionized the field of human genetics, and discovery of 
disease causing mutations continues at an accelerated pace. However, for some human diseases, 
knowledge of the genetic mutation is not sufficient to resolve disease etiology. One such example is 
facioscapulohumeral muscular dystrophy (FSHD), an adult-onset muscular dystrophy characterized 
by progressive weakness in a subset of skeletal muscle groups of the upper body, namely ones in 
the face, shoulders and upper arms. Previous studies showed that FSHD is caused by defective 
epigenetic repression of a macrosatellite array in a region of chromosome 4, which results in mis-
expression of DUX4 in skeletal muscle. DUX4 is a testis-specific transcription factor that activates 
genes involved in germline development, but its mis-expression is toxic to muscle cells. However, 
how DUX4 expression is regulated in normal and pathologic states remained poorly understood. 
A new Fred Hutch collaboration between the labs of Stephen Tapscott (Human Biology and Clinical 
Divisions) and Robert Bradley (Basic Sciences and Public Health Sciences Divisions), spearheaded 
by graduate student Qing Feng and published in eLife, describes a novel feedback loop between a 
quality control pathway called nonsense-mediated decay (NMD) and DUX4. "Our findings indicate 
that regulated RNA degradation contributes to the expression and downstream toxicity of DUX4, and 
also suggest a new mechanism for post-transcriptional autoregulation of transcription factors," said 
Dr. Bradley. 
The study began by reexamining previous data from the Tapscott lab that had used deep 
sequencing of RNA to determine both coding and non-coding RNAs induced by high levels of DUX4 
(Young et al., 2013). This analysis revealed that increased DUX4 levels resulted in increased 
abundance of many coding RNA isoforms with premature stop codons (nonsense mutations) 
upstream of splice junctions, which are predicted to be NMD substrates. To explore whether 
increased levels of NMD substrates were linked to reduced NMD efficiency, the authors compared 
relative levels of a heterologous NMD substrate (β-globin open reading frame with or without a 
premature stop codon) and found that DUX4-expressing myoblasts had two-fold higher levels of the 
β-globin NMD reporter. Globally, DUX4 expression increased levels of predicted NMD substrates for 
all classes of splicing events examined. 
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Next, the authors pursued the mechanism of NMD inhibition following DUX4 expression. Because 
DUX4 expression led to up-regulation, rather than down-regulation, of most NMD factors, a pattern 
reminiscent of UPF1 knockdown cells, the authors hypothesized that protein levels of UPF1, a 
central component of the NMD machinery, might be divorced from its mRNA levels. To test this, the 
authors measured UPF1 levels, as well as levels of NMD factors that were transcriptionally up-
regulated in DUX4-expressing myoblasts (SMG7 and UPF3B) and found that only UPF1 was 
robustly down-regulated. The tight coupling between DUX4 protein production, decreased UPF1 
levels, and increased levels of NMD substrates revealed by time-course analysis suggested that low 
levels of UPF1 and possibly other NMD factors, contributed to inefficient NMD in DUX4-expressing 
myoblasts. To test if DUX4 expression leads to UPF1 degradation, the researchers inhibited the 
proteasome (with MG-132) in DUX4-expressing or control myoblasts and found that UPF1 levels 
were restored in DUX4-expressing, but not control cells. The authors next tested whether DUX4 
itself was an NMD substrate, as it contains a constitutively spliced intron within its 3’ untranslated 
region (3’ UTR). To test this, the authors knocked down UPF1 in FSHD myoblasts and then 
differentiated them into myotubes to induce DUX4 expression. Indeed, DUX4 mRNA expression was 
four-fold higher in UPF1 knockdown cells. 
A characteristic feature of FSHD is the variegated nature of DUX4 expression in muscle cells, 
meaning that only a small percentage of FSHD nuclei are DUX4+. Intriguingly, UPF1 knockdown led 
to an increase in the fraction of DUX4+ nuclei (from 0.3 to 2.1%). Finally, the investigators showed 
that expressing DUX4 in FSHD myotubes led to a five-fold increase in the levels of endogenously 
transcribed DUX4 mRNA. These data led the authors to propose a double negative feedback loop 
where DUX4 indirectly stabilizes its own mRNA by inhibiting NMD. Overall, this study showed that 
impaired RNA quality control mechanisms might contribute to FSHD pathophysiology. "The next key 
step is to test whether these abnormalities in nonsense-mediated decay explain clinical aspects of 
FSHD, such as inflammation in affected muscles, that are not yet understood," concluded Dr. 
Bradley. 
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Image provided by Dr. Robert Bradley 
Schematic of potential double-negative 
feedback loop between DUX4 and NMD, 
in which DUX4 inhibits NMD and NMD 
degrades DUX4 mRNA. 
 
